- Home
- / OCTIMET Oncology
OCTIMET Oncology
Total Funding
$13.4 M
OCTIMET Oncology Summary
Company Summary
- Overview
- OCTIMET develops highly selective MET kinase inhibitors with clean safety profiles from Janssen Pharmaceutica.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Beerse, BE | view all locations
- Website
- http://octimet.com/
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
2 locations detected
Beerse, Vlaanderen HQ
Belgium
30 Turnhoutseweg
Gent, Vlaanderen
Belgium
Pieter van Reysschootlaan 2
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026